Incidence of programmed cell death 1 inhibitor–related pneumonitis in patients with advanced cancer: a systematic review and meta-analysis
M Nishino, A Giobbie-Hurder, H Hatabu… - JAMA …, 2016 - jamanetwork.com
Importance Programmed cell death 1 (PD-1) inhibitor–related pneumonitis is a rare but
clinically serious and potentially life-threatening adverse event. Little is known about its
incidence across different tumor types and treatment regimens. Objective To compare the
incidence of PD-1 inhibitor–related pneumonitis among different tumor types and
therapeutic regimens. Data Sources A PubMed search through November 10, 2015, and a
review of references from relevant articles. For the PubMed search, the following keywords …
clinically serious and potentially life-threatening adverse event. Little is known about its
incidence across different tumor types and treatment regimens. Objective To compare the
incidence of PD-1 inhibitor–related pneumonitis among different tumor types and
therapeutic regimens. Data Sources A PubMed search through November 10, 2015, and a
review of references from relevant articles. For the PubMed search, the following keywords …